In the END group, an unfavorable outcome was observed in 56.8% and 33% of patients at discharge and on the 90 th day, respectively
Janvier, S., Cheyns, K., Canfyn, M., Goscinny, S., De Spiegeleer, B., Vanhee, C., & Deconinck, E
In pig models of intestinal injury, oral BPC-157 reduced inflammatory markers and sealed epithelial gaps within days , translating into fewer symptoms like bloating, gas, and food sensitivities
But they wanted to evaluate the mechanism effects and clinical relevance of BPC-157 in orthopedic and sports medicine, which is what we do, and most of the listeners are doing as well
Additionally, peptide stability during storage and handling affects research outcomes